- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:42 | Pfizer Reaches Agreement with U.S. Government to Lower Drug Costs | ||
| 18:42 | AstraZeneca Enters Agreement to Lower U.S. Drug Prices | ||
| 17:42 | Novo Nordisk to Acquire Akero Therapeutics for $4.7B | ||
| 15:42 | GC Biopharm Secures CMO Rights for Shingles Vaccine Under Clinical Development | ||
| Fr | Bristol Myers Squibb to Acquire Orbital Therapeutics | ||
| Fr | IAVI, Minapharm, & ProBioGen Launch Vaccine & Biologics Manufacturing Partnership in Africa | ||
| Do | Glycovax Pharma, NRC, Montréal U, Partner to Develop Vax Against Pa Infections | ||
| Do | Asahi Kasei Launches Sonanos Next-Gen Excipients | ||
| Do | Bio-Thera Solutions & Intas Pharmaceuticals Expand Partnership | ||
| Do | Expedition Therapeutics Raises $165 Million in Oversubscribed Series A | ||
| Do | Navidea Biopharmaceuticals Files for Chapter 11 Bankruptcy | ||
| Do | Mission Bio Taps Dr. Zivjena Vucetic as Chief Medical Officer | ||
| Mi | groninger Group Builds State-of-the-Art Assembly Hall at Crailsheim HQ | ||
| Mi | KLIFO Gets Approval for New Clinical Trial Supply Facility in Copenhagen | ||
| Mi | Enzene is the First Indian Company to Partner with Virtuosi | ||
| Mi | Lonza Completes New Drug Product Filling Line in Stein, Switzerland | ||
| Mi | BD & Opentrons Accelerate Single-Cell Multiomics Discoveries | ||
| Mi | FairJourney Biologics Appoints Dr. Werner Lanthaler as CEO | ||
| Mi | Boehringer Ingelheim Acquires Preclinical Oncology Asset from Accent Therapeutics | ||
| Mi | Aptamer Enters Development Agreement with Top 3 Global Pharma Company | ||
| Di | Molcure, Boehringer Ingelheim Sign Multi-Year AI-Driven Antibody Discovery Agreement | ||
| Di | Lilly to Invest $1B in India to Expand Manufacturing Capacity | ||
| Di | Steriline to Present Robotic Filling Line at CPHI Frankfurt 2025 | ||
| Di | Piramal Pharma Solutions Implements POD Method at Aurora API Facility | ||
| Di | Kincell Bio Advances Moonlight Bio's T Cell Candidate |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .